gilead glp-1 Can adding Novo's to Gilead's NASH combo help hit fatty liver disease? New trial aims to find out 2 oz (30 Lilly, Gilead lead pharma's M&A

Still, it is clear that GLP-1 new drug treatments like tirzepatide (sold as Mounjaro for diabetes and ZepBound for obesity by Eli Lilly, and as Mounjaro/ZepBound for weight management) and semaglutide (Wegovy/Ozempic by Novo Nordisk) are among the fastest-growing and highest-earning drugs on the planet

Discontinuing obesity medication for patients with demonstrated benefit is bordering unethical. For GLP-1 users like Michael Donnelly-Boylen, who was able to get off of antidepressants and blood pressure medication and stave off longer-term medical care as a result of using GLP-1s for weight management, the drugs are a lifeline. He said since the age of eight, everything he had tried to address his weight had failed

Food and Drug Administration (FDA) announced plans to pursue enforcement action against Hims & Hers and certain compounding pharmacies that sell compounded drugs containing GLP-1 ingredients

In the STEP 1 trial extension, participants regained roughly two-thirds of their prior weight loss within a year of stopping semaglutide